La Fondation MSF

What La Fondation MSF does

La Fondation MSF is a French nonprofit foundation, recognised as being of public utility since 1989, that develops medical innovations specifically designed for humanitarian contexts. It functions as the research and innovation arm of the broader Médecins Sans Frontières movement, targeting vulnerable patients in resource-limited settings where conventional medical tools are unavailable, unaffordable, or unsuitable for the local context. Its products are ultimately provided free of charge to beneficiaries reached through MSF's field operations across more than 70 countries.

The foundation's portfolio spans roughly ten active innovation projects covering diagnostics, therapeutics, digital health, and medical devices. Core offerings include Antibiogo, a mobile AI application that interprets antibiograms to combat antibiotic resistance; AI4CC, an AI-driven cervical cancer screening tool under clinical validation in Malawi; Programme 3D, which produces 3D-printed prosthetics; Optimilk F-60, a ready-to-use therapeutic food for malnourished children; Mini-Lab, a portable bacteriology laboratory; Alerte-Épidémies, an epidemic alert system; SMS AFYA-YETU, a patient monitoring platform; the DKA Calculator for diabetic ketoacidosis management; Micropatchs, a needle-free vaccine delivery technology; and DiaTROPIX, a platform for rapid diagnostic tests. The foundation combines in-house R&D with academic and humanitarian partners including the National Cancer Institute, KTH Royal Institute of Technology, the EQWAL Foundation, and the Nezabutni Foundation in Ukraine.

The foundation is funded entirely through donations and does not commercialise its innovations. Products are transferred to MSF field teams, local health systems, and partner ministries of health. The organisation operates with approximately 47 staff, has secured regulatory milestones including CE marking (June 2022) and ISO 13485:2016 certification (September 2025) for Antibiogo, and publishes several of its tools as open source to enable broader adoption.

Name

La Fondation MSF

Legal name

La Fondation MSF

Website

https://fondation.msf.fr

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

La Fondation MSF is a French nonprofit foundation that develops AI diagnostics, 3D-printed prosthetics, portable laboratories, and therapeutic foods for vulnerable patients in resource-limited settings served by the MSF movement, with all products provided free of charge.

Ownership category

akta.pro rank

Product category

Humanitarian Healthcare Innovation

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (54151), Medical Equipment and Supplies Manufacturing (3391)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH)

Keywords

• Humanitarian medical innovation
• Medical diagnostics software
• Antibiotic resistance testing
• Humanitarian health technology
• Digital health surveillance

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Donations and Philanthropic Funding: La Fondation MSF is funded entirely through donations from individuals, corporations, and institutional donors. Being recognized as being in the public interest since 1989, the foundation benefits from tax advantages for donors including IFI (Property Wealth Tax) deductions.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

La Fondation MSF develops and deploys innovative medical tools and approaches (diagnostic mobile apps, AI screening tools, 3D-printed prosthetics, therapeutic foods, rapid diagnostic tests, and digital surveillance platforms) for humanitarian contexts where Médecins Sans Frontières (MSF) operates. All innovations are designed for resource-limited, low-connectivity settings and are provided free of charge to MSF field programs and partner health facilities.

Product overview

La Fondation MSF operates as a portfolio of humanitarian medical innovations rather than a unified platform. The organization develops multiple distinct products including Antibiogo (mobile application for antibiotic resistance interpretation), AI4CC (cervical cancer screening via HPV testing and AI), Programme 3D (3D-printed medical devices), and various diagnostic tools (rapid tests for measles/meningitis, portable bacteriology lab). These products share the common mission of adapting medical technologies for resource-limited humanitarian contexts but function as independent offerings rather than an integrated platform architecture.

Differentiator

Problem solved

Functional benefit

Brands

• Antibiogo: Free diagnostic aid application to counter antibiotic resistance, available as Android open source app
• AI4CC
• Programme 3D
• Optimilk F-60
• DiaTROPIX
• Mini-Lab
• Alerte-Épidémies
• DKA Calculator
• Micropatchs
• CRASH
• SMS AFYA-YETU

Products and services

• Antibiogo
• AI4CC (Artificial Intelligence for Cervical Cancer)
• Programme 3D
• DiaTROPIX Rapid Diagnostic Tests (TDR Rougeole et Méningite)
• Mini-Lab

Quantifiable outcome

• Antibiogo enables any microbiology lab technician worldwide to interpret antibiograms on their phone
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature10 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Medic MobilecoreTechnology or Integration · 1 January 2020Technology partner providing open source software expertise for digital health projects including Alerte-Épidémies and SMS AFYA-YETU. Medic develops software for community health in low-resource contexts.
• Ministry of Public Health NigercoreStrategic or Co-development PartnerGovernment partner for Alerte-Épidémies platform development and deployment. Requested Epicentre support for COVID-19 surveillance and agreed to expand system for other epidemic diseases.
• EpicentrecoreStrategic or Co-development PartnerMSF research center providing epidemiological expertise for digital health projects. Collaborated on Alerte-Épidémies development and PAVE study for cervical cancer screening.
• National Cancer Institute (NCI)coreStrategic or Co-development PartnerUS government research institution leading the PAVE study consortium for cervical cancer screening. Provided AI algorithm and coordinates global validation study involving 100,000 women.
• KTH Royal Institute of Technology (Sweden)coreTechnology or IntegrationAcademic partner for AI4CC project. Worked on annotation tool development for cervical cancer image analysis dataset.
• ENSAM (École Nationale Supérieure d'Arts et Métiers)minorStrategic or Co-development PartnerFrench engineering school collaborated on Mini-Lab development project.
• Institut de Médecine Tropicale (ITM)minorStrategic or Co-development PartnerPartner for Mini-Lab implementer training.
• EQWAL FoundationminorStrategic or Co-development PartnerNew partner for 3D Program, collaborating on rehabilitation and prosthetic solutions.
• Institut Pasteur DakarcoreStrategic or Co-development PartnerHosts the DiaTROPIX platform for non-profit development and production of rapid diagnostic tests for diseases including measles and meningitis.
• Nezabutni Foundation (Ukraine)minorStrategic or Co-development PartnerUkrainian charitable foundation partnered with MSF Foundation to support vulnerable populations including dementia patients and elderly affected by war.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Wellcome Trust: Major charitable foundation funding scientific research across global health, mental health, and infectious diseases. Operates at vastly greater scale but shares the model of funding health R&D and innovation for humanitarian benefit.
• Gates Foundation (Global Health Division): Largest philanthropic funder of global health R&D, with comparable focus on diagnostics, vaccines, and digital health for low-income countries. Operates as a grantmaker rather than a developer, but competes for partner attention and shapes the same innovation ecosystem.

Direct peers

• Unitaid: Global health partnership hosted by WHO that funds innovation in diagnostics, treatments, and prevention for HIV, TB, malaria, and emerging diseases. Comparable mission and donor-funded model, with similar emphasis on access in low-resource settings.
• FIND (Foundation for Innovative New Diagnostics): Global health nonprofit driving development and adoption of diagnostic tests for poverty-related diseases, with deep focus on low-resource settings. Directly comparable through DiaTROPIX and Mini-Lab work on rapid diagnostics for measles, meningitis, and bacteriology in field conditions.
• Mérieux Foundation: French family foundation focused on fighting infectious diseases globally through laboratory capacity building, applied research, and public health support in low-resource countries. Highly comparable structure and geographic focus to La Fondation MSF.
• Clinton Health Access Initiative (CHAI): Global health nonprofit that negotiates pricing, scales access, and implements health programs in low-income countries, with deep work in HIV, cancer screening, and diagnostics. Comparable to La Fondation MSF's mission of expanding access to medical innovations in resource-limited settings.
• DNDi (Drugs for Neglected Diseases Initiative): Patient-focused nonprofit R&D organization that develops new treatments for neglected diseases affecting low-resource populations. Closely comparable to La Fondation MSF in mission, funding model (donor-funded), and focus on diseases of poverty where commercial markets fail.
• Institut Pasteur: French nonprofit research foundation focused on infectious disease biology, immunology, and vaccine/diagnostic development. Directly comparable through the DiaTROPIX partnership and shared mission of developing biomedical tools for public health.
• PATH: Global health nonprofit that develops and delivers health innovations including diagnostics, devices, and digital health tools for low-income countries. Comparable in cross-cutting portfolio approach, mission focus, and deployment through partners in Africa and Asia.

Others

• Epicentre (MSF Research Center): MSF-affiliated research center conducting epidemiology and clinical studies in humanitarian settings, and an active research partner of La Fondation MSF on AI4CC, Alerte-Épidémies, and SMS AFYA-YETU. Adjacent within the MSF ecosystem rather than a competitor.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCjfM5JNsCglnNzk1MNtC6MQ
• LinkedInlinkedin.com/company/la-fondation-msf

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about La Fondation MSF